ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,104Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 337

$905K Total Retail Price of All Prescriptions

Rank: 14 out of 337

631 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 631 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 15,062 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 739 680 1 1
ATORVASTATIN CALCIUM 703 668 2 7
OMEPRAZOLE 551 493 3 4
LEVOTHYROXINE SODIUM 545 515 4 5
LOSARTAN POTASSIUM 484 466 5 15
BYSTOLIC 461 446 6 91
FUROSEMIDE 444 422 7 8
ENALAPRIL MALEATE 442 404 8 37
METOPROLOL TARTRATE 425 422 9 6
LISINOPRIL 421 390 10 2
GLIPIZIDE 381 356 11 45
CARVEDILOL 340 335 12 73
BENICAR 274 261 13 110
CRESTOR 255 245 14 29
METFORMIN HCL 253 240 15 12
AMLODIPINE BESYLATE 252 249 16 3
BENICAR HCT 239 216 17 166
CITALOPRAM HBR 232 209 18 17
LOSARTAN-HYDROCHLOROTHIAZIDE 210 205 19 60
NAMENDA 196 196 20 35
CLOPIDOGREL 195 193 21 42
LIPITOR 183 175 22 33
ALPRAZOLAM 183 178 22 78
HYDROCHLOROTHIAZIDE 181 177 24 9
ZOLPIDEM TARTRATE 171 163 25 23
PAROXETINE HCL 156 138 26 46
PROAIR HFA 152 128 27 38
LOVASTATIN 151 144 28 24
MELOXICAM 151 146 28 54
FOSINOPRIL SODIUM 145 132 30 144
TRAMADOL HCL 145 121 30 32
PLAVIX 142 142 32 74
TAMSULOSIN HCL 128 116 33 25
ATENOLOL 125 119 34 10
WARFARIN SODIUM 123 123 35 11
PRAVASTATIN SODIUM 120 120 36 14
DIOVAN 118 109 37 26
IBUPROFEN 112 103 38 64
ATELVIA 110 95 39 199
AMOXICILLIN 106 91 40 193
PREDNISONE 105 97 41 40
JANUVIA 105 105 41 81
GABAPENTIN 98 86 43 20
AZOR 96 96 44 239
HYDROCODONE-ACETAMINOPHEN 95 92 S3 45 13
CARISOPRODOL 89 65 R 46 180
METOPROLOL SUCCINATE 83 83 47 21
WELCHOL 82 79 48 178
DIOVAN HCT 78 78 49 88
AZITHROMYCIN 78 70 49 51
TERAZOSIN HCL 77 65 51 136
CIPROFLOXACIN HCL 76 75 52 71
DONEPEZIL HCL 75 75 53 22
SPIRIVA 73 73 54 43
AMLODIPINE BESYLATE-BENAZEPRIL 73 73 54 97
ISOSORBIDE MONONITRATE ER 73 73 54 70
AMITRIPTYLINE HCL 71 67 R 57 75
DILTIAZEM ER 70 69 58 169
SERTRALINE HCL 69 63 59 18
ESCITALOPRAM OXALATE 67 67 60 66
TRIBENZOR 67 55 60 224
ALLOPURINOL 62 62 62 28
DEXILANT 60 60 63 182
TRAZODONE HCL 60 47 63 16
SYNTHROID 59 51 65 41
QUINAPRIL HCL 58 58 66 50
NEXIUM 57 47 67 56
MOMETASONE FUROATE 54 52 68 228
MECLIZINE HCL 54 46 68 117
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 48 70 31
METHIMAZOLE 50 50 71 319
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.